The epidemiological impact of rotavirus vaccination programs in the United States and Mexico

Mathematical and Statistical Estimation Approaches in Epidemiology

Volumn , Issue , 2009, Pages 303-323

  Shim, Eunha ^a   Castillo Chavez, Carlos ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Age structured model; Rotarix; RotaTeq; Rotavirus; Vaccination

Indexed keywords

EID: 79952565361     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-90-481-2313-1_12     Document Type: Chapter

References (25)

1. Anderson, R. M., & May, R. M. (1985). Age-related changes in the rate of disease transmission: Implications for the design of vaccination programmes. J Hygiene 94: 365-436.
2. Bresee, J. S., Parashar, U. D., Widdowson, M. A., Gentsch, J. R., Steele, A. D., & Glass, R. I. (2005). Update on rotavirus vaccines. Pediatr Infect Dis J 24(11):947-952.
3. CDC. (2008). Statistics and Surveillance: July 2006-June 2007 Table Data (Publication. Retrieved May 27, 2008: http://www.cdc.gov/vaccines/stats-surv/ nis/data/tables0607.htm.
4. Clark, H. F., Bernstein, D. I., Dennehy, P. H., Offit, P., Pichichero, M., Treanor, J., et al. (2004). Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. J Pediatr 144(2):184-190.
5. Delayed onset and diminished magnitude of rotavirus activity - United States, November 2007-May 2008. (2008). MMWR Morb Mortal Wkly Rep 57(25):697-700.
6. Dennehy, P. H. (2008). Rotavirus vaccines: An overview. Clin Microbiol Rev 21(1), 198-208.
7. Dennehy, P. H., Cortese, M. M., Begue, R. E., Jaeger, J. L., Roberts, N. E., Zhang, R., et al. (2006). A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in US children. Pediatr Infect Dis J 25(12):1123-1131.
8. Glass, R. I., Bresee, J. S., Turcios, R., Fischer, T. K., Parashar, U. D., & Steele, A. D. (2005). Rotavirus vaccines: Targeting the developing world. J Infect Dis 192(Suppl 1):S160-S166.
9. Glass, R. I., & Parashar, U. D. (2006). The promise of new rotavirus vaccines. N Engl J Med 354(1), 75-77.
10. Grimwood, K., & Bines, J. E. (2007). Rotavirus vaccines must perform in low-income countries too. Lancet 370(9601):1739-1740.
11. Hethcote, H. W. (1997). An age-structured model for pertussis transmission. Math Biosci 145(2):89-136.
12. Hethcote, H.W. (1999). Simulations of pertussis epidemiology in the United States: Effects of adult booster vaccinations. Math Biosci 158(1):47-73.
13. Hethcote, H. W., Horby, P., & McIntyre, P. (2004). Using computer simulations to compare pertussis vaccination strategies in Australia. Vaccine 22(17-18):2181-2191.
14. International Data Base, Table 028. (2008). from http://www.census.gov/ ipc/www/idb/idbprint.html.
15. Nakagomi, O., & Cunliffe, N. A. (2007). Rotavirus vaccines: Entering a new stage of deployment. Curr Opin Infect Dis 20(5):501-507.
16. Newall, A. T., MacIntyre, R., Wang, H., Hull, B., & Macartney, K. (2006). Burden of severe rotavirus disease in Australia. J Paediatr Child Health 42(9):521-527.
17. Parashar, U. D., Bresee, J. S., Gentsch, J. R., & Glass, R. I. (1998). Rotavirus. Emerg Infect Dis 4(4):561-570.
18. Podewils, L. J., Antil, L., Hummelman, E., Bresee, J., Parashar, U. D., & Rheingans, R. (2005). Projected cost-effectiveness of rotavirus vaccination for children in Asia. J Infect Dis 192(Suppl 1):S133-S145.
19. Rheingans, R. D., Constenla, D., Antil, L., Innis, B. L., & Breuer, T. (2007). Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries. Rev Panam Salud Publica 21(4):205-216.
20. Roberts, L. (2004). Vaccines. Rotavirus vaccines' second chance. Science, 305(5692), 1890-1893.
21. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule - United States, February 2006-May 2007. (2008). MMWR Morb Mortal Wkly Rep 57(15):398-401.
22. Ruuska, T., & Vesikari, T. (1990). Rotavirus disease in Finnish children: Use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 22(3):259-267.
23. Velazquez, F. R., Matson, D. O., Calva, J. J., Guerrero, L., Morrow, A. L., Carter-Campbell, S., et al. (1996). Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 335(14):1022-1028.
24. Vesikari, T., Giaquinto, C., & Huppertz, H. I. (2006). Clinical trials of rotavirus vaccines in Europe. Pediatr Infect Dis J 25(1 Suppl):S42-S47.
25. Walker, D. G., & Rheingans, R. (2005). The cost-effectiveness of rotavirus vaccines. Expert Rev. Pharmacoeconomics Outcomes Res 5(5):593-601.